Molecular mechanisms of amyloid oligomers toxicity.
暂无分享,去创建一个
[1] I. Parker,et al. Single-channel Ca2+ imaging implicates Aβ1–42 amyloid pores in Alzheimer’s disease pathology , 2011, The Journal of cell biology.
[2] R. Kayed,et al. Astrocytes contain amyloid‐β annular protofibrils in Alzheimer's disease brains , 2011, FEBS letters.
[3] R. Kayed,et al. Amyloid-β Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain*♦ , 2011, The Journal of Biological Chemistry.
[4] J. Marsh,et al. Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers , 2010, Molecular Neurodegeneration.
[5] R. Wetzel,et al. Abeta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated. , 2010, Journal of molecular biology.
[6] H. Lashuel,et al. Amyloidogenic protein-membrane interactions: mechanistic insight from model systems. , 2010, Angewandte Chemie.
[7] Nicole Bowles,et al. Oligomers of β-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model , 2010, Experimental Neurology.
[8] Chunjiang Yu,et al. Endocytic pathways mediating oligomeric Aβ42 neurotoxicity , 2010, Molecular Neurodegeneration.
[9] R. Nussinov,et al. Polymorphism in Alzheimer Aβ Amyloid Organization Reflects Conformational Selection in a Rugged Energy Landscape , 2010, Chemical reviews.
[10] M. Lösche,et al. Size-dependent neurotoxicity of beta-amyloid oligomers. , 2010, Archives of biochemistry and biophysics.
[11] E. Capetillo-Zarate,et al. Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease , 2010, Acta Neuropathologica.
[12] T. Zako. Amyloid oligomers , 2010, The FEBS journal.
[13] J. Sweatt,et al. Loss of α7 Nicotinic Receptors Enhances β-Amyloid Oligomer Accumulation, Exacerbating Early-Stage Cognitive Decline and Septohippocampal Pathology in a Mouse Model of Alzheimer's Disease , 2010, The Journal of Neuroscience.
[14] L. Breydo,et al. Fibrillar Oligomers Nucleate the Oligomerization of Monomeric Amyloid β but Do Not Seed Fibril Formation* , 2009, The Journal of Biological Chemistry.
[15] C. Glabe,et al. Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction , 2009, Neurobiology of Disease.
[16] John Hardy,et al. The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal , 2009, Journal of neurochemistry.
[17] S. Pimplikar. Reassessing the amyloid cascade hypothesis of Alzheimer's disease. , 2009, The international journal of biochemistry & cell biology.
[18] Ghiam Yamin. NMDA receptor–dependent signaling pathways that underlie amyloid β‐protein disruption of LTP in the hippocampus , 2009, Journal of neuroscience research.
[19] G. Zamponi. Faculty Opinions recommendation of Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. , 2009 .
[20] John W. Gilbert,et al. Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers , 2009, Nature.
[21] R. Kayed,et al. Annular Protofibrils Are a Structurally and Functionally Distinct Type of Amyloid Oligomer* , 2009, Journal of Biological Chemistry.
[22] W. Klein,et al. Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers , 2009, Proceedings of the National Academy of Sciences.
[23] M. Lösche,et al. Soluble amyloid beta-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: implications for cell toxicity. , 2008, Biophysical journal.
[24] F. LaFerla,et al. Aβ inhibits the proteasome and enhances amyloid and tau accumulation , 2008, Neurobiology of Aging.
[25] C. Glabe. Structural Classification of Toxic Amyloid Oligomers* , 2008, Journal of Biological Chemistry.
[26] L. Juliano,et al. Amyloid-β Binds to the Extracellular Cysteine-rich Domain of Frizzled and Inhibits Wnt/β-Catenin Signaling* , 2008, Journal of Biological Chemistry.
[27] R. Cappai,et al. Delineating the Mechanism of Alzheimer’s Disease Aβ Peptide Neurotoxicity , 2008, Neurochemical Research.
[28] W. Klein,et al. Amyloid beta oligomers induce impairment of neuronal insulin receptors , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] D. Selkoe,et al. Soluble Aβ Inhibits Specific Signal Transduction Cascades Common to the Insulin Receptor Pathway* , 2007, Journal of Biological Chemistry.
[30] C. Cotman,et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers , 2007, Molecular Neurodegeneration.
[31] Jonathan S. Weissman,et al. The structural basis of yeast prion strain variants , 2007, Nature.
[32] J. Rain,et al. von Hippel–Lindau binding protein 1-mediated degradation of integrase affects HIV-1 gene expression at a postintegration step , 2007, Proceedings of the National Academy of Sciences.
[33] Kim N. Green,et al. Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.
[34] M. D'Andrea,et al. Aβ peptides can enter the brain through a defective blood–brain barrier and bind selectively to neurons , 2007, Brain Research.
[35] W. Klein,et al. Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine* , 2007, Journal of Biological Chemistry.
[36] R. Kayed,et al. Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct* , 2007, Journal of Biological Chemistry.
[37] Bernardo L Sabatini,et al. Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.
[38] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[39] S. Maeda,et al. A Ganglioside-induced Toxic Soluble Aβ Assembly , 2007, Journal of Biological Chemistry.
[40] Frank M LaFerla,et al. Androgens Regulate the Development of Neuropathology in a Triple Transgenic Mouse Model of Alzheimer's Disease , 2006, The Journal of Neuroscience.
[41] A. Gliozzi,et al. Natively folded HypF-N and its early amyloid aggregates interact with phospholipid monolayers and destabilize supported phospholipid bilayers. , 2006, Biophysical journal.
[42] Ralf Langen,et al. Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. , 2006, American journal of physiology. Endocrinology and metabolism.
[43] R. Kayed,et al. Soluble Amyloid Oligomers Increase Bilayer Conductance by Altering Dielectric Structure , 2006, The Journal of general physiology.
[44] G. Bu,et al. LRP in Amyloid‐β Production and Metabolism , 2006 .
[45] R. Nusse,et al. Wnt Signaling: Multiple Pathways, Multiple Receptors, and Multiple Transcription Factors* , 2006, Journal of Biological Chemistry.
[46] Jonathan S. Weissman,et al. The physical basis of how prion conformations determine strain phenotypes , 2006, Nature.
[47] Christopher M. Dobson,et al. Prefibrillar Amyloid Aggregates Could Be Generic Toxins in Higher Organisms , 2006, The Journal of Neuroscience.
[48] R. Kayed,et al. ERK1/2 Activation Mediates Aβ Oligomer-induced Neurotoxicity via Caspase-3 Activation and Tau Cleavage in Rat Organotypic Hippocampal Slice Cultures* , 2006, Journal of Biological Chemistry.
[49] J. Busciglio,et al. Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons , 2006, The Journal of Neuroscience.
[50] J. Quinn,et al. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. , 2006, Human molecular genetics.
[51] P. Lansbury,et al. Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? , 2006, Quarterly Reviews of Biophysics.
[52] C. Almeida,et al. β-Amyloid Accumulation Impairs Multivesicular Body Sorting by Inhibiting the Ubiquitin-Proteasome System , 2006, The Journal of Neuroscience.
[53] C. Glabe. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease , 2006, Neurobiology of Aging.
[54] M. Gallagher,et al. A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.
[55] R. Kayed,et al. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis , 2006, Neurology.
[56] I. Mook‐Jung,et al. Amyloid peptide attenuates the proteasome activity in neuronal cells , 2005, Mechanisms of Ageing and Development.
[57] X. Chen,et al. Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease , 2005 .
[58] R. Riek,et al. 3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .
[59] C. Ross,et al. What is the role of protein aggregation in neurodegeneration? , 2005, Nature Reviews Molecular Cell Biology.
[60] P. Greengard,et al. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses , 2005, Neurobiology of Disease.
[61] P. Axelsen,et al. Promotion of Oxidative Lipid Membrane Damage by Amyloid β Proteins , 2005 .
[62] P. T. Nguyen,et al. Dendritic Spine Abnormalities in Amyloid Precursor Protein Transgenic Mice Demonstrated by Gene Transfer and Intravital Multiphoton Microscopy , 2005, The Journal of Neuroscience.
[63] Ian Parker,et al. Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.
[64] F. LaFerla,et al. Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[65] D. Selkoe,et al. γ-Secretase Exists on the Plasma Membrane as an Intact Complex That Accepts Substrates and Effects Intramembrane Cleavage* , 2005, Journal of Biological Chemistry.
[66] R. Rydel,et al. Nucleation-Dependent Polymerization Is an Essential Component of Amyloid-Mediated Neuronal Cell Death , 2005, The Journal of Neuroscience.
[67] Ralph A. Nixon,et al. Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study , 2005, Journal of neuropathology and experimental neurology.
[68] R. Kayed,et al. Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases* , 2004, Journal of Biological Chemistry.
[69] Rushana Azimova,et al. Amyloid Peptide Channels , 2004, The Journal of Membrane Biology.
[70] C. Duyckaerts,et al. Subcellular topography of neuronal Abeta peptide in APPxPS1 transgenic mice. , 2004, The American journal of pathology.
[71] J. B. Watson,et al. Amyloid β Prevents Activation of Calcium/Calmodulin-Dependent Protein Kinase II and AMPA Receptor Phosphorylation During Hippocampal Long-Term Potentiation , 2004 .
[72] T. Bayer,et al. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. , 2004, The American journal of pathology.
[73] U. Aebi,et al. Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide. , 2004, Journal of molecular biology.
[74] Fabrizio Chiti,et al. Prefibrillar Amyloid Protein Aggregates Share Common Features of Cytotoxicity* , 2004, Journal of Biological Chemistry.
[75] D. Selkoe,et al. Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. , 2004, Protein and peptide letters.
[76] O. Vitolo,et al. Dendrite and dendritic spine alterations in alzheimer models , 2004, Journal of neurocytology.
[77] D. Teplow,et al. Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s disease , 2004, Neurobiology of Aging.
[78] C. Almeida,et al. Oligomerization of Alzheimer's β-Amyloid within Processes and Synapses of Cultured Neurons and Brain , 2004, The Journal of Neuroscience.
[79] P. Lansbury,et al. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.
[80] I. Nishimoto,et al. Characterization of the toxic mechanism triggered by Alzheimer's amyloid‐β peptides via p75 neurotrophin receptor in neuronal hybrid cells , 2003, Journal of neuroscience research.
[81] C. Dobson,et al. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution , 2003, Journal of Molecular Medicine.
[82] E. Gazit,et al. The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. , 2003, Biochemistry.
[83] B. Hyman,et al. Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes , 2003, Journal of Cell Science.
[84] X. Roucou,et al. p75 Neurotrophin Receptor Protects Primary Cultures of Human Neurons against Extracellular Amyloid β Peptide Cytotoxicity , 2003, The Journal of Neuroscience.
[85] M. Mattson,et al. Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.
[86] Ann Marie Schmidt,et al. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain , 2003, Nature Medicine.
[87] Carl W. Cotman,et al. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.
[88] P. Greengard,et al. Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. , 2002, The American journal of pathology.
[89] Rustam Azimov,et al. The channel hypothesis of Alzheimer’s disease: current status , 2002, Peptides.
[90] G. Perini,et al. Role of p75 Neurotrophin Receptor in the Neurotoxicity by β-amyloid Peptides and Synergistic Effect of Inflammatory Cytokines , 2002, The Journal of experimental medicine.
[91] M. D'Andrea,et al. Intracellular accumulation of β-amyloid1–42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer’s disease , 2002, Neuroscience.
[92] B. Gilchrest,et al. Amyloid β Binds Trimers as Well as Monomers of the 75-kDa Neurotrophin Receptor and Activates Receptor Signaling* , 2002, The Journal of Biological Chemistry.
[93] D. Selkoe,et al. Intraneuronal Aβ42 accumulation in Down syndrome brain , 2002 .
[94] C. Glabe. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer’s disease , 2001, Journal of Molecular Neuroscience.
[95] J. Nathans,et al. Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains , 2001, Nature.
[96] Oliver Wirths,et al. Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice , 2001, Neuroscience Letters.
[97] P. Lansbury,et al. Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. , 2001, Biochemistry.
[98] J. Troncoso,et al. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. , 2001, Archives of pathology & laboratory medicine.
[99] P. A. Peterson,et al. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease , 2001, Histopathology.
[100] Z. Makita,et al. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer’s disease , 2001, Brain Research.
[101] Raphael C. Lee,et al. Surfactant Sealing of Membranes Permeabilized by Ionizing Radiation , 2000, Radiation research.
[102] Kang Hu,et al. High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.
[103] Masahiro Kawahara,et al. Alzheimer's β-Amyloid, Human Islet Amylin, and Prion Protein Fragment Evoke Intracellular Free Calcium Elevations by a Common Mechanism in a Hypothalamic GnRH Neuronal Cell Line* , 2000, The Journal of Biological Chemistry.
[104] C. Masters,et al. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease , 1999, Annals of neurology.
[105] L. Lue,et al. Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .
[106] A. Yang,et al. Intracellular Accumulation of Insoluble, Newly Synthesized Aβn-42 in Amyloid Precursor Protein-transfected Cells That Have Been Treated with Aβ1–42* , 1999, The Journal of Biological Chemistry.
[107] D. Butterfield,et al. Temporal relations among amyloid β-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses , 1998, Journal of Molecular Neuroscience.
[108] G. Lynch,et al. Amyloid β protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein , 1998 .
[109] A. Yang,et al. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1‐42 pathogenesis , 1998, Journal of neuroscience research.
[110] R. Doms,et al. Detection of a Novel Intraneuronal Pool of Insoluble Amyloid β Protein that Accumulates with Time in Culture , 1998, The Journal of cell biology.
[111] B. Gilchrest,et al. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. , 1997, The Journal of clinical investigation.
[112] C. Kawas,et al. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. , 1997, The Journal of clinical investigation.
[113] B. Bechinger,et al. Structure and Functions of Channel-Forming Peptides: Magainins, Cecropins, Melittin and Alamethicin , 1997, The Journal of Membrane Biology.
[114] C. Glabe,et al. Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, Aβ1–42, in differentiated PC12 cells , 1997, Brain Research.
[115] X. Chen,et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease , 1996, Nature.
[116] M. Bothwell. p75NTR: A Receptor After All , 1996, Science.
[117] P. Greengard,et al. Regulated Formation of Golgi Secretory Vesicles Containing Alzheimer β-Amyloid Precursor Protein (*) , 1995, The Journal of Biological Chemistry.
[118] C. Glabe,et al. Intracellular Aβ1-42 Aggregates Stimulate the Accumulation of Stable, Insoluble Amyloidogenic Fragments of the Amyloid Precursor Protein in Transfected Cells (*) , 1995, The Journal of Biological Chemistry.
[119] H. Hansma,et al. Applications for atomic force microscopy of DNA. , 1995, Biophysical journal.
[120] M. Mattson. Calcium and Neuronal Injury in Alzheimer's Disease , 1994, Annals of the New York Academy of Sciences.
[121] L. Butcher,et al. Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[122] E. Rojas,et al. Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[123] Mark P. Mattson,et al. β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease , 1993, Trends in Neurosciences.
[124] K. Imahori,et al. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[125] E. Rojas,et al. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[126] M. Mizuguchi,et al. Differential distribution of cellular forms of β-amyloid precursor protein in murine glial cell cultures , 1992, Brain Research.
[127] M. Mattson,et al. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[128] P. Läuger,et al. Nonlinear electrical effects in lipid bilayer membranes. II. Integration of the generalized Nernst-Planck equations. , 1969, Biophysical journal.
[129] A. Parsegian,et al. Energy of an Ion crossing a Low Dielectric Membrane: Solutions to Four Relevant Electrostatic Problems , 1969, Nature.
[130] I. Parker,et al. Single-channel Ca 2+ imaging implicates A 1–42 amyloid pores in Alzheimer’s disease pathology , 2011 .
[131] Yasir,et al. ‘ Protection of synapses against Alzheimer ’ slinked toxins : Insulin signaling prevents the pathogenic binding of A oligomers , 2009 .
[132] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[133] R. Cappai,et al. Delineating the mechanism of Alzheimer's disease A beta peptide neurotoxicity. , 2008, Neurochemical research.
[134] S. Maeda,et al. A ganglioside-induced toxic soluble Abeta assembly. Its enhanced formation from Abeta bearing the Arctic mutation. , 2007, The Journal of biological chemistry.
[135] F. LaFerla,et al. Intracellular amyloid-beta in Alzheimer's disease. , 2007, Nature reviews. Neuroscience.
[136] V. Della-Bianca,et al. Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in β-amyloid peptide-dependent cell death , 2007, Journal of Molecular Neuroscience.
[137] G. Bu,et al. LRP in amyloid-beta production and metabolism. , 2006, Annals of the New York Academy of Sciences.
[138] R. Nixon,et al. Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.
[139] A. Eckert,et al. Mitochondrial dysfunction induced by disease relevant AbetaPP and tau protein mutations. , 2006, Journal of Alzheimer's disease : JAD.
[140] Michela Gallagher,et al. A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.
[141] P. Greengard,et al. Regulation of NMDA receptor trafficking by amyloid-beta. , 2005, Nature neuroscience.
[142] X. Chen,et al. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[143] R. Riek,et al. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[144] P. Axelsen,et al. Promotion of oxidative lipid membrane damage by amyloid beta proteins. , 2005, Biochemistry.
[145] R. Leapman,et al. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. , 2005, Science.
[146] J. B. Watson,et al. Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation. , 2004, Journal of neurophysiology.
[147] C. Finch,et al. Self-assembly of Abeta(1-42) into globular neurotoxins. , 2003, Biochemistry.
[148] Yves-Alain Barde,et al. The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. , 2002, Nature neuroscience.
[149] M. D'Andrea,et al. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. , 2002, Neuroscience.
[150] D. Selkoe,et al. Intraneuronal Abeta42 accumulation in Down syndrome brain. , 2002, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[151] T. Bayer,et al. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. , 2001, Neuroscience letters.
[152] P. Greengard,et al. Intraneuronal Abeta42 accumulation in human brain. , 2000, The American journal of pathology.
[153] P. A. Peterson,et al. beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. , 2000, The Journal of biological chemistry.
[154] P. Greengard,et al. Intraneuronal Aβ42 Accumulation in Human Brain , 2000 .
[155] L. Lue,et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. , 1999, The American journal of pathology.
[156] C. Hertel,et al. Beta-amyloid binds to p57NTR and activates NFkappaB in human neuroblastoma cells. , 1998, Journal of neuroscience research.
[157] G. Lynch,et al. Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. , 1998, The Journal of comparative neurology.
[158] X. Chen,et al. Amyloid- (cid:98) peptide–Receptor for Advanced Glycation Endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease , 1997 .
[159] A. Schmidt,et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. , 1996, Nature.
[160] M. Mattson,et al. beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. , 1993, Trends in neurosciences.